Promising Opioid Treatment For Young Adults
A new treatment program for opioid addiction, Buprenorphine Treatment for Young Adults, was announced at the recent National Institute on Drug Abuse's (NIDA) Conference.
Buprenorphine Treatment for Young Adults is based on research conducted by NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA). Buprenorphine is a medication that is effective in relieving drug cravings in adults, but its effectiveness among younger patients had not been shown.
NIDA and SAMHSA's research found that young adults who received longer term treatment with buprenorphine were more likely to stay in treatment and less likely to relapse than their peers who received short term detox and no follow-up medication.
The Buprenorphine Treatment for Young Adults product includes a training program that examines young adult opioid use and buprenorphine's effectiveness.
Why Is This Important?
Opioid addiction is one of the most common substance abuse problems and also one that many find extremely hard to treat. Rates of opioid use among young adults have been rising over the last decade, particularly use of prescription opioid painkillers.
Despite shorter addiction histories, young adults are just as likely to relapse after detoxification as adults, and require more effective treatments. This evidence that medication therapy in youths is effective may help young adults get the treatment they need.